Correlation of preoperative serum prostate-specific antigen, clinical stage, and biopsy Gleason score with seminal vesicle involvement in prostate adenocarcinoma

被引：0
|
作者：
Ormsby, AH [1 ]
Skacel, M [1 ]
Brainard, JA [1 ]
Zippe, CD [1 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 1999年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
49
引用
收藏
页码：548 / 548
页数：1
相关论文
共 50 条
  • [31] Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer
    Figg, WD
    Franks, ME
    Venzon, D
    Duray, P
    Cox, MC
    Linehan, WM
    Van Bingham, W
    Eastham, JA
    Reed, E
    Sartor, O
    WORLD JOURNAL OF UROLOGY, 2004, 22 (06) : 425 - 430
  • [32] Prostate adenocarcinoma. Predictive clinical model of seminal vesicle involvement
    Algarra, Ruben
    Maria Velis, Jose
    Tienza, Antonio
    Merino, Imanol
    Barba, Javier
    Tolosa, Egoitz
    Rincon, Anibal
    Rioja, Jorge
    Zudaire, Javier
    Pascual, Ignacio
    ARCHIVOS ESPANOLES DE UROLOGIA, 2013, 66 (06): : 576 - 583
  • [33] Skin metastasis of prostate adenocarcinoma to glans penis showing no correlation with serum prostate-specific antigen level
    Kobashi-Katoh, Rika
    Tanioka, Miki
    Takahashi, Kenzo
    Miyachi, Yoshiki
    JOURNAL OF DERMATOLOGY, 2009, 36 (02): : 106 - 108
  • [34] PROSTATE ADENOCARCINOMA USING GLEASON SCORES CORRELATES WITH PROSTATE-SPECIFIC ANTIGEN AND PROSTATE ACID-PHOSPHATASE MEASUREMENTS
    SHIH, WJ
    GROSS, K
    MITCHELL, B
    COLLINS, J
    WIERZBINSKI, B
    MAGOUN, S
    RYO, UY
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1992, 84 (12) : 1049 - 1050
  • [35] Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin tables) based on cases from 2000 to 2005
    Makarov, Danil V.
    Trock, Bruce J.
    Humphreys, Elizabeth B.
    Mangold, Leslie A.
    Walsh, Patrick C.
    Epstein, Jonathan I.
    Partin, Alan W.
    UROLOGY, 2007, 69 (06) : 1095 - 1101
  • [36] NOMOGRAM FOR PREDICTING THE RISK OF NODE INVOLVEMENT IN PROSTATE-CANCER GIVEN PRETREATMENT PROSTATE-SPECIFIC ANTIGEN AND GLEASON SCORE - REPLY
    ROACH, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (02): : 510 - 510
  • [37] Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score
    Huang, Ying
    Isharwal, Sumit
    Haese, Alexander
    Chun, Felix K. H.
    Makarov, Danil V.
    Feng, Ziding
    Han, Misop
    Humphreys, Elizabeth
    Epstein, Jonathan I.
    Partin, Alan W.
    Veltri, Robert W.
    BJU INTERNATIONAL, 2011, 107 (10) : 1562 - 1569
  • [38] Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy
    Janbaziroudsari, Hamid
    Mirzaei, Arezoo
    Maleki, Nasrollah
    BULLETIN DU CANCER, 2016, 103 (09) : 730 - 734
  • [39] Molecular forms of serum prostate-specific antigen - The clinical value of percent free prostate-specific antigen
    Abrahamsson, PA
    Lilja, H
    Oesterling, JE
    UROLOGIC CLINICS OF NORTH AMERICA, 1997, 24 (02) : 353 - +
  • [40] Prostate-specific antigen in nipple aspiration fluid: Menstrual cycle variability and correlation with serum prostate-specific antigen
    Mitchell, G
    Sibley, PEC
    Wilson, APM
    Sauter, E
    A'Hern, R
    Eeles, RA
    TUMOR BIOLOGY, 2002, 23 (05) : 287 - 297
12345